SNTI Stock Plummets as Senti Biosciences Misses EPS for Q4 2023
Source: tilialucida / Shutterstock.com
Senti Biosciences (NASDAQ:SNTI) recently unveiled the financial outcomes for the fourth quarter of 2023.
- Senti Biosciences recorded earnings per share of -42 cents, falling significantly short of analyst projections of -23 cents.
- The company refrained from divulging its revenue figures for the quarter, leaving investors speculating the extent of financial turbulence.
Arising from InvestorPlace Media, read more at: Senti Biosciences Q4 2023 Earnings Report.
©2024 InvestorPlace Media, LLC